Brian M. Stolz's most recent trade in BridgeBio Pharma Inc was a trade of 1,595 Restricted Stock Units done . Disclosure was reported to the exchange on Aug. 16, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
BridgeBio Pharma Inc | Brian M. Stolz | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2020 | 1,595 | 23,937 | - | - | Restricted Stock Units | |
BridgeBio Pharma Inc | Brian M. Stolz | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2020 | 1,595 | 25,167 (0%) | 0% | - | Common Stock | |
BridgeBio Pharma Inc | Brian M. Stolz | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.53 per share. | 16 Aug 2020 | 552 | 24,615 (0%) | 0% | 28.5 | 15,749 | Common Stock |
BridgeBio Pharma Inc | Brian M. Stolz | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2020 | 183,727 | 183,727 | - | - | Stock Option (Right to Buy) | |
BridgeBio Pharma Inc | Brian M. Stolz | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2020 | 25,532 | 25,532 | - | - | Restricted Stock Units |